Article
Immunocorrelates of CAF family adjuvants
1 Oct 2018
Abstract excerpt
The development of the CAF family adjuvant was initiated around 20 years ago when Statens Serum Institut was preparing its first generation protein based recombinant subunit vaccine against tuberculosis for clinical testing, but realized that there were no clinically relevant adjuvants available that would support the strong CMI response needed. Since then the aim for the adjuvant research at Statens Serum...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
